Kura Oncology (KURA) Leases (2023 - 2025)
Kura Oncology (KURA) has disclosed Leases for 3 consecutive years, with $7.3 million as the latest value for Q4 2025.
- Quarterly Leases rose 25.83% to $7.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.3 million through Dec 2025, up 25.83% year-over-year, with the annual reading at $7.3 million for FY2025, 25.83% up from the prior year.
- Leases for Q4 2025 was $7.3 million at Kura Oncology, down from $7.5 million in the prior quarter.
- The five-year high for Leases was $8.1 million in Q1 2025, with the low at $2.9 million in Q2 2023.
- Average Leases over 3 years is $6.4 million, with a median of $6.8 million recorded in 2023.
- Peak annual rise in Leases hit 118.21% in 2024, while the deepest fall reached 17.02% in 2024.
- Over 3 years, Leases stood at $7.0 million in 2023, then decreased by 17.02% to $5.8 million in 2024, then rose by 25.83% to $7.3 million in 2025.
- According to Business Quant data, Leases over the past three periods came in at $7.3 million, $7.5 million, and $7.9 million for Q4 2025, Q3 2025, and Q2 2025 respectively.